GSS genetic signatures limited

'Genetic Signatures’ EasyScreenTM Respiratory Detection targets...

  1. 4,445 Posts.
    lightbulb Created with Sketch. 337
    'Genetic Signatures’ EasyScreenTM Respiratory Detection targets include an assay for pan-coronaviruses. The new strain that has originated from China, currently known as 2019-nCoV, can be identified without changes to the assay due to the unique capabilities of Genetic Signatures 3base™ technology. The Company is contacting various agencies to determine what interest may exist for the test. '

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
36.5¢
Change
0.000(0.00%)
Mkt cap ! $82.90M
Open High Low Value Volume
36.5¢ 36.5¢ 36.5¢ $657 1.8K

Buyers (Bids)

No. Vol. Price($)
2 11082 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 45991 2
View Market Depth
Last trade - 10.22am 08/07/2025 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.